Two therapeutic challenges: Facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream
dc.contributor.author | Bilaç D.B. | |
dc.contributor.author | Ermertcan A.T. | |
dc.contributor.author | Şahin M.T. | |
dc.contributor.author | Öztürkcan S. | |
dc.date.accessioned | 2024-07-22T08:22:05Z | |
dc.date.available | 2024-07-22T08:22:05Z | |
dc.date.issued | 2009 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.DOI-ID | 10.1111/j.1468-3083.2008.02668.x | |
dc.identifier.issn | 14683083 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18918 | |
dc.language.iso | English | |
dc.subject | Adolescent | |
dc.subject | Calcitriol | |
dc.subject | Dermatologic Agents | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Immunosuppressive Agents | |
dc.subject | Tacrolimus | |
dc.subject | Vitiligo | |
dc.subject | calcipotriol | |
dc.subject | pimecrolimus | |
dc.subject | adolescent | |
dc.subject | anamnesis | |
dc.subject | case report | |
dc.subject | clinical feature | |
dc.subject | depigmentation | |
dc.subject | drug efficacy | |
dc.subject | face | |
dc.subject | female | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | hypopigmentation | |
dc.subject | letter | |
dc.subject | priority journal | |
dc.subject | skin examination | |
dc.subject | treatment response | |
dc.subject | vitiligo | |
dc.title | Two therapeutic challenges: Facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream | |
dc.type | Letter |